Amisulpride Augmentation Therapy for Clozapine-resistant Schizophrenic Patients

Clinical trial NCT01105481 · COMPLETED

Trial details

NCT number: NCT01105481
Sponsor: National Health Research Institutes, Taiwan
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Treatment-resistant Schizophrenia

Start date: 2006-05-01
Primary completion: 2008-03-01
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.